4 Things To Watch As FDA Flexes New Inspection Powers
New guidance from the U.S. Food and Drug Administration claims sweeping authority to block pharmaceutical sales if drugmakers resist agency requests to interview employees or scour internal records during inspections, experts...To view the full article, register now.
Already a subscriber? Click here to view full article